Figure 2From: Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report TC imaging: A baseline TC (December 2011); B simulation TC (March 2012); C follow up (June 2013); D last follow up (February 2014). Back to article page